All articles by Soumya Sharma

Soumya Sharma

ODAIA wins $25m funding to boost commercial insights platform for pharma

Expansion of ODAIA’s platform will allow pharma companies to rapidly deliver life changing therapies to patients.

Verismo Therapeutics’ SynKIR-110 receives fast track designation from FDA

SynKIR-110 is an investigational drug to treat mesothelin-expressing mesothelioma, ovarian cancer and cholangiocarcinoma.